Bausch Health Companies Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report, dated May 14, 2025, details the results of the Annual Meeting of Shareholders held on May 13, 2025. The filing covers the voting outcomes for four specific proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting results rather than financial performance data.
Material Changes and Voting Results
Shareholders voted on four proposals with the following outcomes:
- Proposal 1: Election of Directors. All ten nominees were elected to the Board of Directors to serve until the 2026 Annual Meeting. Notable nominees included Thomas J. Appio, Brett M. Icahn, and John A. Paulson. While all were elected, Brett M. Icahn received the highest number of withheld votes (15,164,500) among the nominees.
- Proposal 2: Advisory Vote on Executive Compensation. Shareholders approved the compensation of Named Executive Officers on a non-binding basis. Approximately 93.8% of votes cast were in favor (199,584,790 For vs. 13,233,305 Against).
- Proposal 3: 2025 Employee Stock Purchase Plan. Shareholders approved the plan with strong support. Approximately 98.1% of votes cast were in favor (209,243,257 For vs. 3,660,841 Against).
- Proposal 4: Appointment of Auditors. Shareholders appointed PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending in 2026. The vote was overwhelmingly in favor (266,669,018 For vs. 4,014,796 Withheld).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to reporting the historical results of the shareholder vote.
Key Facts for Investor Verification
- Verify the tenure of the newly elected directors, specifically noting the term ends at the 2026 Annual Meeting.
- Review the specific compensation details referenced in the Management Proxy Circular to understand the basis for the advisory vote approval.
- Confirm the terms of the newly approved 2025 Employee Stock Purchase Plan.
- Note the significant number of broker non-votes (56,339,806) across all proposals, indicating shares held in street name where brokers did not have discretionary voting authority.